These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8183931)

  • 1. High-affinity binding of short peptides to major histocompatibility complex class II molecules by anchor combinations.
    Hammer J; Belunis C; Bolin D; Papadopoulos J; Walsky R; Higelin J; Danho W; Sinigaglia F; Nagy ZA
    Proc Natl Acad Sci U S A; 1994 May; 91(10):4456-60. PubMed ID: 8183931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promiscuous and allele-specific anchors in HLA-DR-binding peptides.
    Hammer J; Valsasnini P; Tolba K; Bolin D; Higelin J; Takacs B; Sinigaglia F
    Cell; 1993 Jul; 74(1):197-203. PubMed ID: 8334703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allele specificity of structural requirement for peptides bound to HLA-DRB1*0405 and -DRB1*0406 complexes: implication for the HLA-associated susceptibility to methimazole-induced insulin autoimmune syndrome.
    Matsushita S; Takahashi K; Motoki M; Komoriya K; Ikagawa S; Nishimura Y
    J Exp Med; 1994 Sep; 180(3):873-83. PubMed ID: 8064238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides.
    Vogt AB; Kropshofer H; Kalbacher H; Kalbus M; Rammensee HG; Coligan JE; Martin R
    J Immunol; 1994 Aug; 153(4):1665-73. PubMed ID: 7519208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular determinants of peptide binding to two common rhesus macaque major histocompatibility complex class II molecules.
    Dzuris JL; Sidney J; Horton H; Correa R; Carter D; Chesnut RW; Watkins DI; Sette A
    J Virol; 2001 Nov; 75(22):10958-68. PubMed ID: 11602736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naturally processed peptides from two disease-resistance-associated HLA-DR13 alleles show related sequence motifs and the effects of the dimorphism at position 86 of the HLA-DR beta chain.
    Davenport MP; Quinn CL; Chicz RM; Green BN; Willis AC; Lane WS; Bell JI; Hill AV
    Proc Natl Acad Sci U S A; 1995 Jul; 92(14):6567-71. PubMed ID: 7604034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide motif for the rat MHC class II molecule RT1.Da: similarities to the multiple sclerosis-associated HLA-DRB1*1501 molecule.
    Duyar H; Dengjel J; de Graaf KL; Wiesmüller KH; Stevanović S; Weissert R
    Immunogenetics; 2005 Apr; 57(1-2):69-76. PubMed ID: 15711804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific and general HLA-DR binding motifs: comparison of algorithms.
    Borrás-Cuesta F; Golvano J; García-Granero M; Sarobe P; Riezu-Boj J; Huarte E; Lasarte J
    Hum Immunol; 2000 Mar; 61(3):266-78. PubMed ID: 10689116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of single substituted promiscuous and designer peptides to purified DRB1*0101.
    Macklin KD; Conti-Fine BM
    Biochem Biophys Res Commun; 1998 Jan; 242(2):322-6. PubMed ID: 9446793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Several common HLA-DR types share largely overlapping peptide binding repertoires.
    Southwood S; Sidney J; Kondo A; del Guercio MF; Appella E; Hoffman S; Kubo RT; Chesnut RW; Grey HM; Sette A
    J Immunol; 1998 Apr; 160(7):3363-73. PubMed ID: 9531296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of peptide-binding motifs for two disease associated HLA-DR13 alleles using an M13 phage display library.
    Davenport MP; Quinn CL; Valsasnini P; Sinigaglia F; Hill AV; Bell JI
    Immunology; 1996 Aug; 88(4):482-6. PubMed ID: 8881746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pattern search method for putative anchor residues in T cell epitopes.
    Hobohm U; Meyerhans A
    Eur J Immunol; 1993 Jun; 23(6):1271-6. PubMed ID: 7684684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New ligands for HLA DRB1*0301 by random selection of favourable amino acids ranked by competition studies with undecapeptide amide sublibraries.
    Jung C; Kalbus M; Fleckenstein B; Melms A; Jung G; Wiesmüller KH
    J Immunol Methods; 1998 Oct; 219(1-2):139-49. PubMed ID: 9831395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural diversity of human class II histocompatibility molecules induced by peptide ligands.
    Georges B; Loing E; Neveu R; Melnyk O; Gras-Masse H; Auriault C
    FEBS Lett; 2000 Sep; 481(3):249-54. PubMed ID: 11007973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of peptide-HLA binding by an enzyme-linked assay and its application to the detailed peptide motifs for HLA-DR9 (DRB1*0901).
    Fujisao S; Nishimura Y; Matsushita S
    J Immunol Methods; 1997 Feb; 201(2):157-63. PubMed ID: 9050937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative implication of peptide residues in binding to major histocompatibility complex class I H-2Db: application to the design of high-affinity, allele-specific peptides.
    Hudrisier D; Mazarguil H; Oldstone MB; Gairin JE
    Mol Immunol; 1995 Aug; 32(12):895-907. PubMed ID: 7565816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editing of the HLA-DR-peptide repertoire by HLA-DM.
    Kropshofer H; Vogt AB; Moldenhauer G; Hammer J; Blum JS; Hämmerling GJ
    EMBO J; 1996 Nov; 15(22):6144-54. PubMed ID: 8947036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of HLA-DR9 (DRB1*0901)-binding peptide motifs using a phage fUSE5 random peptide library.
    Fujisao S; Matsushita S; Nishi T; Nishimura Y
    Hum Immunol; 1996 Feb; 45(2):131-6. PubMed ID: 8882411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyrotropin receptor epitopes and their relation to histocompatibility leukocyte antigen-DR molecules in Graves' disease.
    Inaba H; Martin W; De Groot AS; Qin S; De Groot LJ
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2286-94. PubMed ID: 16595602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implication of HLA-DR residues at positions 67, 71, and 86 in interaction between HLA-DR11 and peptide HA306-320.
    Zeliszewski D; Golvano JJ; Gaudebout P; Dorval I; Freidel C; Gebuhrer L; Betuel H; Borras-Cuesta F; Sterkers G
    J Immunol; 1993 Dec; 151(11):6237-47. PubMed ID: 7504016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.